CI
MRNA icon

Capital International’s Moderna MRNA Stock Holding History

Capital International’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,330
Closed -$964K – 155
2023
Q3 		$964K Hold
9,330
– – 0.06% 148
2023
Q2 		$1.13M Sell
9,330
-4,240
-31% -$566K 0.06% 149
2023
Q1 		$2.08M Buy
13,570
+5,259
+63% +$868K 0.13% 138
2022
Q4 		$1.49M Buy
+8,311
New +$1.36M 0.1% 140
2022
Q1 		– Sell
-6,962
Closed -$1.77M – 167
2021
Q4 		$1.77M Buy
6,962
+5,088
+272% +$1.49M 0.09% 135
2021
Q3 		$721K Sell
1,874
-94
-5% -$34.7K 0.04% 150
2021
Q2 		$462K Sell
1,968
-8,129
-81% -$1.45M 0.03% 154
2021
Q1 		$1.32M Buy
+10,097
New +$1.46M 0.08% 139

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International's MRNA Position: Q4 2023 in Review

Capital International sold out of Moderna (MRNA) in Q4 2023, closing a stake of 9,330 shares — an estimated $964K sold.

Capital International first reported a position in MRNA in Q1 2021 and held it in 8 quarters. The position peaked at $2.08M in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Capital International reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Capital International sold 9,330 Moderna shares in Q4 2023, an estimated $964K.
  • Capital International first reported a position in Moderna in Q1 2021 and held it in 8 quarters.
  • Capital International's Moderna position peaked at $2.08M in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Capital International's 13F filing for Q4 2023, filed 13 Feb 2024.